Pemphigus is divided into two major subtypes: pemphigus vulgaris and pemphigus foliaceus. Oral corticosteroids are the primary treatment modality for pemphigus, while other therapeutic options ...
Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...
Pemphigus vulgaris is an uncommon, persistent autoimmune disorder that causes blisters on the skin and mucous membranes. It is regarded as the most common variant of the autoimmune blistering disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback